Raquel E. Izumi - Feb 15, 2023 Form 4 Insider Report for Vincerx Pharma, Inc. (VINC)

Role: Officer, Director
Signature: By: /s/ Raquel E. Izumi
Stock symbol: VINC
Transactions as of: Feb 15, 2023
Transactions value $: $0
Form type: 4
Date filed: 2/16/2023, 03:05 PM
Previous filing: Dec 14, 2022
Next filing: Aug 10, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VINC	Stock Option (right to buy)	Award	$0	+90K		$0.00	90K	Feb 15, 2023	Common Stock	90K	$1.17	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Option vests in twenty-four equal monthly installments starting from February 15, 2023.

Remarks:

President and Chief Operations Officer Represents the 3rd tranche of stock option grants previously approved by the Compensation Committee on August 25, 2022.